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Summary
Vaccinia virus capping enzyme is a heterodimer of D1 (844-aa) and D12 (287-aa) polypeptides
that executes all three steps in m7GpppRNA synthesis. The D1 subunit comprises an N-terminal
RNA triphosphatase (TPase)–guanylyltransferase (GTase) module and a C-terminal guanine-N7-
methyltransferase (MTase) module. The D12 subunit binds and allosterically stimulates the
MTase module. Crystal structures of the complete D1•D12 heterodimer disclose the TPase and
GTase as members of the triphosphate tunnel metalloenzyme and covalent nucleotidyltransferase
superfamilies, respectively, albeit with distinctive active site features. An extensive TPase-GTase
interface clamps the GTase nucleotidyltransferase and OB domains in a closed conformation
around GTP. Mutagenesis confirms the importance of the TPase-GTase interface for GTase
activity. The D1•D12 structure complements and rationalizes four decades of biochemical studies
of this enzyme (the first capping enzyme to be purified and characterized) and provides new
insights to the origins of the capping systems of other large DNA viruses.
Introduction
The 5′ cap is a distinctive feature of eukaryal cellular and viral messenger RNA that is
required for mRNA stability and efficient translation. The cap consists of 7-
methylguanosine linked via an inverted 5′-5′ triphosphate bridge to the initiating
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nucleoside of the transcript. The cap is formed by enzymatic modification of nascent pre-
mRNAs synthesized by cellular or viral RNA polymerases. Capping entails three enzymatic
reactions (Figure 1A). The 5′ triphosphate end of the pre-mRNA is first hydrolyzed to a
diphosphate by RNA 5′ triphosphatase (TPase). The diphosphate RNA is then capped with
GMP by RNA guanylyltransferase (GTase) via a two-step mechanism in which: (i) GTase
reacts with GTP to form a covalent enzyme-(lysyl-Nζ)-GMP intermediate and PPi and (ii)
GMP is transferred from GTase to the ppRNA end to form GpppRNA. Finally, the
GpppRNA cap is converted to m7GpppRNA by AdoMet:RNA(guanine-N7)-
methyltransferase (MTase). This pathway was elucidated via the analysis of the poxvirus
capping enzyme purified from infectious vaccinia virions (Martin and Moss, 1975, 1976;
Martin et al., 1975; Shuman and Hurwitz, 1981; Shuman et al., 1980; Venkatesan et al.,
1980). The same pathway is conserved in all eukarya, several large DNA viruses, and
reovirus (a dsRNA virus), though many other RNA viruses use alternative strategies to cap
their RNAs (Decroly et al., 2012).
Whereas the three capping reactions are universal in eukarya and DNA viruses, there is a
remarkable diversity in the genetic and physical organization of the cap-forming enzymes in
different taxa and in different viruses, ranging from separately encoded TPase, GTase, and
MTase enzymes that have no physical interactions with each other (e.g., in fission yeast), to
separately encoded enzymes that form complexes in trans (e.g. budding yeast), to fusions of
two of the capping enzymes within a single polypeptide (metazoa, plants, baculovirus), to
fusion of all three enzymes in a single polypeptide (poxviruses). There is also a complete
divergence in the structure and catalytic mechanism of the TPase enzymes between taxa.
The TPases fall into two classes: the metal-dependent RNA triphosphatases found in fungi,
protozoa, and large DNA viruses (poxviruses, baculoviruses, Chlorella virus and mimivirus)
versus the metal-independent cysteine-phosphatase-type RNA triphosphatases found in
metazoans and plants (Shuman, 2002). In principle, these differences can be exploited to
develop novel anti-infective agents that inhibit pathogen capping enzymes and they also
provide instructive clues to eukaryal phylogeny and evolution of large DNA viruses
(Shuman, 2002).
Vaccinia virus capping enzyme was the first capping enzyme to be purified and
characterized (Martin et al., 1975). It is a heterodimer of 844-aa and 287-aa polypeptides,
encoded by the D1 and D12 genes, respectively, that efficiently executes all three steps in
m7GpppRNA synthesis. Consequently, vaccinia capping enzyme has been used widely as a
reagent for capping and cap-labeling RNAs in vitro. The physical organization of vaccinia
capping enzyme is unique (Figure 1B). D1-(1-545) constitutes an autonomous monomeric
triphosphatase–guanylyltransferase domain (TPase-GTase) (Myette and Niles, 1996a, b; Yu
and Shuman, 1996). The MTase domain consists of D1-(548-844) heterodimerized with the
D12 subunit (Cong and Shuman, 1992; De la Pena et al., 2007; Higman et al., 1992; Higman
et al., 1994; Mao and Shuman, 1994). The MTase active site is located entirely within D1-
(548-844), which has a weak intrinsic methyltransferase activity that is stimulated
allosterically by D12 (Higman et al., 1994; Mao and Shuman, 1994; Schwer et al., 2006).
The capping apparatus is organized differently in other large DNA viruses. Mimivirus, a
parasite of amoeba, encodes an 1170-aa trifunctional capping enzyme (MimiCE) that
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resembles vaccinia D1, but it does not encode a homolog of vaccinia D12 (Figure 1B).
Deletion analysis identified MimiCE-(1-668) as an autonomous TPase-GTase unit
[analogous to vaccinia D1-(1-545)] and MimiCE-(1-237) as a minimal autonomous TPase
domain (Benarroch et al., 2008). Baculoviruses, which replicate in arthropod hosts, encode a
bifunctional TPase-GTase capping enzyme analogous to vaccinia D1-(1-545) (Gross and
Shuman, 1998) (Figure 1B), but do not encode a cap guanine-N7 methyltransferase. The N-
terminal 236-aa segment of baculovirus capping enzyme comprises an autonomous TPase
catalytic domain (Martins and Shuman, 2001). Chlorella virus PBCV-1 encodes separate
TPase and GTase enzymes (Häkansson et al., 1997; Gong and Shuman, 2002) (Figure 1B),
but does not appear to encode a cap guanine-N7 methyltransferase. Physical separation of
the mimivirus, baculovirus, and Chlorella virus TPase and GTase domains contrasts with
the inability to isolate stand-alone TPase and GTase modules derived from vaccinia D1-
(1-545) (Myette and Niles, 1996b; Yu et al., 1997).
The domains and three active sites of vaccinia capping enzyme have been charted in detail
by mutagenesis with in vitro and in vivo readouts of TPase, GTase and MTase activities
(Cong and Shuman, 1995; Gong and Shuman, 2003; Ho et al., 2000; Mao and Shuman,
1994, 1996; Saha and Shuman, 2001; Saha et al., 2003; Schwer et al., 2006; Yu et al., 1997;
Yu and Shuman, 1996; Zheng and Shuman, 2008a, b). Analyses of the vaccinia MTase were
guided initially by crystal structures of the homologous eukaryal cellular cap
methyltransferase (Fabrega et al., 2004) and later by the crystal structure of the vaccinia
D1(MTase)•D12 heterodimer (De la Pena et al., 2007). The combined collections of cellular
and poxvirus cap MTase structures with bound substrates and products conferred great
power in interpreting the extensive functional data, yielding important insights into: (i) the
basis for cap methyl acceptor specificity; (ii) the mechanism of catalysis of methyl transfer;
(iii) a unique methyl donor conformation and AdoMet binding pocket in the poxvirus MTase
versus the cellular homolog (with strong implications for anti-poxviral inhibitor design); (iv)
protein conformational steps accompanying substrate binding; and (v) the kinetic
mechanism of D12’s stimulation of D1-MTase activity. Moving forward, we aspired to
attain a comparably deep understanding of the TPase and GTase components of the vaccinia
capping system.
Here we report the crystal structure of the full-length D1•D12 heterodimer with AdoHcy in
the methyltransferase active site and with or without GTP in the guanylyltransferase active
site at 2.8 and 2.9 Å resolution, respectively. The structures reveal that: (i) the poxvirus
RNA triphosphatase domain is a bona fide “triphosphate tunnel metalloenzyme” (TTM) akin
to the mimivirus and fungal TPases (Benarroch et al., 2008; Lima et al., 1999), and (ii) the
guanylyltransferase domain consists of nucleotidyltransferase (NTase) and OB-fold (OB)
modules as in previously characterized cellular/viral capping enzymes and DNA ligases
(Shuman and Lima, 2004). Closely packed contacts between the TPase and GTase modules
mutually stabilize their active conformations and account for the prior inability to isolate
autonomous TPase and GTase catalytic domains. Furthermore, by introducing alanine
mutations at the TPase-GTase interface, we identify lesions that decouple the TPase and
GTase. The TPase-GTase contacts also clamp the NTase and OB domains of the GTase in a
closed conformation, restricting inter-domain flexibility. In addition to structure-guided
Kyrieleis et al. Page 3
Structure. Author manuscript; available in PMC 2015 March 04.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
functional studies we discuss the insights into the evolution of the capping apparatus
afforded by the structure of vaccinia D1•D12.
Results
Crystallization and structure determination of the full-length vaccinia D1•D12 heterodimer
The full-length vaccinia D1 and D12 subunits were co-expressed in bacteria and purified as
a 1:1 heterodimer. The D1•D12 protein, supplemented variously with AdoHcy, AdoMet,
m7GpppG, GTP and magnesium, crystallized in three different lattices, monoclinic (P21,
forms 1 and 3) and triclinic (P1, form 2). The structure of the D1•D12 complex was solved
by molecular replacement combined with cross-crystal averaging over four data sets,
including native (2.9 Å resolution), platinum derivative (3.2 Å) and selenomethionine
derivative (3.5 Å) crystals in space-group P21 (form 1) and a native crystal (2.9 Å) in space
group P1 (see Materials and Methods and Table 1 for crystallographic statistics). Models of
the triclinic and the monoclinic crystals were refined independently to R/Rfree values of
25.4/29.8 and 25.2/29.4, respectively (Table 1). The two refined structures are extremely
similar except for minor differences in domain orientation. In all determined structures,
AdoHcy is found in the MTase active site. No ligand was observed in the TPase site.
Diffraction data collected for GTP co-crystals in the P1 form were used to derive the 2.8 Å
structure of D1•D12 with GTP in the GTase active site, which was refined to R/Rfree values
of 21.0/25.9. The final D1•D12 models included maximally 822/844 amino acids of the D1
subunit (lacking residues 28–33 in the TPase domain, 320-323 and usually 408-411 in the
GTase, 531–543 from the linker between the GTase and MTase and, in the GTP bound
structures, 554-561 in the MTase) and 283/287 amino acids of the D12 subunit (lacking
residues 120–123). The structures have excellent stereochemistry, with >99% of residues in
allowed regions of a Ramachandran plot (Table 1).
The overall structure of the D1•D12 complex resembles an elongated, U-shape with
dimensions of 110 Å × 50 Å × 46 Å (Figure 1C). One lobe of this U-shape consists of the
TPase tunnel and the N-terminal part of the NTase domain of the GTase and has a length of
56 Å. The other lobe is formed by the D12 subunit and is 60 Å long. These are connected by
the distal half of the GTase NTase domain, the OB module, and the entire D1 MTase
domain with a width of 110 Å. The relative arrangement of the three domains together with
the D12 subunit opens a deep cleft with dimensions of 24 Å in width and 30 Å in depth
(Figure 1C). The folding topology of the vaccinia capping enzyme is depicted in Figure 1D.
The TPase domain
The structure of the vaccinia TPase domain (residues 1-225) clearly indicates that it belongs
to the triphosphate tunnel metalloenzyme (TTM) family of RNA triphosphatases, as shown
by its structural homology to mimivirus TPase (Z=12.8 from DALI (Holm and Sander,
1993)) (Benarroch et al., 2008) and yeast Cet1 (Z=9.8) (Lima et al., 1999)(Figures 2 and
S1). Similar to these other TPases, the central core of the vaccinia TPase consists of an anti-
parallel eight-stranded β-barrel (β1 to β8; Figure 1D) that forms a topologically closed
hydrophilic tunnel (Figure 2B-D). The vaccinia, mimivirus and yeast Cet1 TPases differ
mainly in the position of the peripheral α helices that pack against the outer walls of the
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tunnel (Figure S1). Cet1 has four helices (αA-αD in Figure S1A) exclusively located below
the bottom floor of the tunnel, three of which are conserved in the mimivirus and vaccinia
TPases (as αA, αB and αE in Figure S1B and C). Vaccinia TPase has two additional helices
located on the roof of the tunnel (αC and αD in Figure S1C, connecting strands β3 to β4
and β7 to β8, respectively). In contrast to the viral TPases, yeast Cet1 is an obligate
homodimer (Hausmann et al., 2003; Lima et al., 1999) which explains the more complex
structure of the Cet1 peripheral helices. An alignment of the viral and yeast TPase structures
is shown in Figure S1D.
The TPase active site
The TPase tunnel accommodates the 5′ triphosphate end of the substrate RNA together with
at least one divalent metal ion, which promotes hydrolysis of the γ-phosphate (Lima et al.,
1999). The tunnel is lined with charged residues that are partitioned such that one half of the
internal surface (the ‘roof’) is populated almost exclusively by basic residues (Lys65, Lys75,
Arg77, Lys79, Lys107, Lys161, Lys163, exceptionally Glu144) and the other half (the
‘floor’) by acidic residues (Glu37, Glu39, Glu126, Asp159, Glu192, Glu194, exceptionally
Arg122) (Figure 2B). These include two conserved signature motifs of tunnel-forming
TPases (motifs A and C, Figure S1D), each containing two metal-coordinating glutamates:
Glu37 and Glu39 in β1 and Glu192 and Glu194 in β8 for Vaccinia TPase, which correspond
to Glu307, Glu309, Glu494 and Glu496 in Cet1 and Glu37, Glu39, Glu212 and Glu214 in
mimivirus, respectively (Figure 2B-D). Previous mutational analysis of the vaccinia TPase
showed that six acidic and three basic residues are critical for enzymatic activity: Glu37,
Glu39, Arg77, Lys107, Glu126, Asp159, Lys161, Glu192 and Glu194 (Gong and Shuman,
2003; Yu et al., 1997; Yu and Shuman, 1996).
Cet1 and mimivirus TPases contain a third motif (motif B), which comprises three basic side
chains (Arg454, Lys456 and Arg458 in Cet1) projecting from strand β6 on the side wall of
the tunnel. Based on the Cet1 complex with sulfate anion, these are predicted to coordinate
the negatively charged RNA 5′ triphosphate (Arg454 to the β-phosphate, Arg458 to the γ-
phosphate), either by direct hydrogen bonding or by water-mediated hydrogen bonds (Lima
et al., 1999). Motif B is critical for the TPase activity of fungal and Chlorella virus TPase
(Bisaillon and Shuman, 2001; Gong and Shuman, 2002; Pei et al., 1999; Pei et al., 2000).
Vaccinia TPase lacks a basic motif B, the equivalent positions being substituted by Glu144,
Val146 and Leu148 (Figure S1D). Instead, two basic side chains on strand β7, Lys161 and
Lys163 are positioned to functionally replace respectively Arg458 and Arg454 in Cet1.
Indeed Lys161 is essential for vaccinia TPase function; its mutation to alanine or glutamine
elicits a 50-fold decrement in TPase activity with no impact on GTase activity (Gong and
Shuman, 2003). However Lys163 has been shown to be dispensable for vaccinia TPase
activity (Gong and Shuman, 2003).
Vaccinia TPase Arg77 (β3) and Lys107 (β4) are the counterparts of Arg393 and Lys409 in
Cet1 and are essential for activity (Gong and Shuman, 2003; Yu et al., 1997) probably by
coordinating the γ-phosphate. The active site of the vaccinia TPase is completed by two
acidic side chains: Glu126 (β5) and Asp159 (β7). Glu126 (Glu433 in Cet1) is proposed to
serve as a general base catalyst that coordinates and abstracts a proton from the water
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nucleophile that attacks the γ-phosphorus. Consistent with this, mutating Glu126 effaces
vaccinia TPase activity (Gong and Shuman, 2003). An acidic functional group is apparently
important at position 159, insofar as D159E retains full TPase activity, whereas D159A and
D159N are 11% and 2% as active as wild-type TPase (Gong and Shuman, 2003). The
equivalent aspartate in Cet1 (Asp471) forms a salt bridge with Cet1 Arg469, which in turn is
thought to make a hydrogen bond with one of the waters in the octahedral manganese
coordination complex. In vaccinia TPase, the arginine position is occupied by Thr157 (β7)
which is unlikely to fulfill the same role.
Lys75 and Lys79 (in strand β3) are constituents of the triphosphate tunnel of vaccinia TPase
that are conserved in the capping enzymes of other Poxviridae (Figure S1D) but not as basic
residues in Cet1 or mimivirus TPase. To test whether Lys75 and Lys79 are relevant for
vaccinia TPase activity, we changed them to alanine in the context of D1(1-545) and
assayed the recombinant proteins (Figure S1E) for TPase activity in parallel with wild-type
D1(1-545). The K75A and K79A mutations had no deleterious effect on TPase function
(Figure S1E). We also mutated 12 other charged or hydrophilic residues that either project
into the TPase tunnel from the β-strands (Arg65, Glu122, Ser124, Glu144, Gln150, Lys152,
Thr157, Ser190 and Thr196) or out to solvent from the tunnel rim (Arg128, Lys152 on one
end of the tunnel; Arg142, Glu112 on the other end). Most of the positions chosen for this
alanine scan are conserved among poxvirus TPases except (Arg65, Thr157 and Thr196), but
not in Cet1 or mimivirus TPase (Figure S1D). Our criterion for judging an amino acid
important for capping enzyme function is that its replacement by alanine causes at least a
four-fold decrement in activity. By this test, none of the mutated residues are important for
NTP phosphohydrolase activity.
The guanylyltransferase
Capping enzyme guanylyltransferases (GTases), with the exception of those of some dsRNA
viruses, share a common fold with ATP-dependent DNA ligases (Shuman and Lima, 2004)
consisting of two domains: an N-terminal nucleotidyltransferase (NTase) and a C-terminal
OB-fold (OB). Structural homology searches with vaccinia GTase (residues 226-530) using
DALI identified four capping enzyme GTases. In order of similarity they are: Chlorella
virus GTase (DALI Z=14.7) (Hakansson et al., 1997), the GTase domain of human capping
enzyme (Z=14.1) (Chu et al., 2011), Candida albicans Cgt1 (Z=11.5) (Fabrega et al., 2003)
and Saccharomyces cerevisiae Ceg1 (Z=10.3) (Gu et al., 2010). The vaccinia NTase fold
consists of: (i) a central six-stranded antiparallel β-sheet (β13,12,11,14,15,16), (ii) a four-
stranded mixed β-sheet (β9,18,17,10), and (iii) three α-helices (αF,G,H) (Figure 1D, 3AC).
A structure-based amino acid sequence alignment of the viral and human GTases is shown
in Figure S2. We will focus our discussion on a comparison of the vaccinia and Chlorella
virus GTases.
The vaccinia and Chlorella NTase domains differ most strongly at their N-termini. Chlorella
virus GTase has an additional module – composed of a two-stranded β-sheet (β1-β2) and an
α-helix (αA) – at its N-terminus that packs against the central β-sheet (Figure 3C). In the
vaccinia NTase domain, this helix is replaced by a long loop that runs across the central β-
sheet, and by the β9 strand, which is absent in the Chlorella virus enzyme.
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The C-terminal OB module comprises a five-stranded anti-parallel β-sheet
(β21,20,19,25,26) with an inserted three-stranded antiparallel β-sheet (β22,23,24) located
beneath the five-stranded β-sheet (Figure 1D, 3A, S3). The inserted β-sheet is a unique
feature of the vaccinia GTase. Towards the C-terminus there are two α helices (αI and αJ),
flanking the three- and the five-stranded β-sheet, respectively (Figure 1D). The OB domain
of Chlorella virus GTase lacks helix αI and has instead a C-terminal helix (αG) that folds
back on the NTase domain (Figure 3C). In vaccinia GTase, the equivalent region interacts
weakly with αH of the NTase domain (Figure 3A) and leads into a long, disordered loop
(530-544) connecting the GTase with the MTase; this loop is protease-sensitive in the native
vaccinia capping enzyme (De la Pena et al., 2007; Shuman, 1989).
The NTase and the OB-fold domains of the GTase form a deep substrate binding cleft.
Chlorella virus GTase was crystallized in two different conformations: an unreactive open
conformation with bound GTP, and a catalytically active closed conformation with bound
GTP that could be converted in situ into the covalent enzyme-GMP adduct upon addition of
manganese (Figure 3C)(Hakansson et al., 1997). Even in the absence of nucleotide, the
vaccinia GTase resembles the closed conformation of the GTP-bound Chlorella virus GTase
(Figure 3E), whereas for human GTase (with sulphate in the active site) a range of
conformations from closed to half-open were observed (Chu et al., 2011). In vaccinia
GTase, the residues 467EVG468 at the tip of the surface loop between strands β23 and β24 of
the OB module interacts with two surface loops of the NTase module, thereby reinforcing
the closed conformation of the GTase. Specifically, the Glu467 main chain carbonyl accepts
a hydrogen bond from the Lys306 main chain amide; the Val468 carbonyl makes van der
Waals contacts with the Trp310-Cζ2,CH2 indole atoms; and Val468-Cγ1 makes van der
Waals contacts to His281-Cδ,Nε. The tip of this vaccinia OB-fold loop is physically at the
same place as the turn of the extra N-terminal β-hairpin of the Chlorella virus NTase
domain.
The guanylyltransferase active site
Co-crystals of vaccinia capping enzyme with GTP revealed density for the nucleotide in one
of the two D1•D12 complexes in the asymmetric unit (Figure S5C). GTP binds between the
six-stranded and four-stranded β-sheets of the NTase module and induces no large scale
changes in the enzyme, only affecting the conformations of a few side chains in direct
contact with the ligand. The defining features of the vaccinia GTase active site are six
conserved motifs that interact with the guanine base (motifs IIIa and IV), the ribose
hydroxyls (motifs I and III) and the triphosphate moiety (motifs I, V and VI) of GTP
(Shuman and Lima, 2004; Wang et al., 1997). Vaccinia GTase Motif I (260KTDGIP265) is
located in the loop between β10 and β11 and contains Lys260, the active site lysine
nucleophile to which GMP becomes covalently attached (Niles and Christen, 1993).
The guanosine nucleoside adopts a syn conformation in the vaccinia GTase. The base stacks
between Ile315 (β15, motif IIIa) and Ile378 (β17, motif IV), which correspond to Phe146
and Ile216 in Chlorella virus GTase. Guanine specificity is conferred by hydrogen bonding
between amino acid side chains and the polar atoms of the nucleobase (Lys350 to O6 and
N7, Thr239 and Asp390 to N2). The triphosphate conformation in the vaccinia complex
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differs from that in the closed form of the Chlorella virus GTP complex and is not optimal
for catalysis. In the active Chlorella GTase, the Lys82-Nζ nucleophile is 3.2 Å from the α-
phosphorus and is apical to the bridging α-β O3A oxygen of the PPi leaving group. In the
vaccinia GTase, Lys260 contacts the GTP α and β phosphate oxygens, but the α-phosphate
is not oriented properly for a nucleophilic attack by Lys260 to form the enzyme-GMP
adduct. Lys260-Nζ is too distant (3.8 Å) from the α-phosphorus and makes an acute angle
with respect to the PPi leaving group. We envision that this unfavorable geometry is
rectified when the essential Mg2+ ion is bound in the active site. This ion is likely to be
bound by the essential motif IV acidic residue (Glu375 in Vaccinia and Asp213 in Chlorella
virus GTases) that is conserved in all ATP-dependent DNA and RNA ligases, NAD+-
dependent DNA ligases, and GTP-dependent mRNA capping enzymes (Cong and Shuman,
1995; Sawaya and Shuman, 2003; Wang et al., 1997). The metal is postulated to promote
catalysis by: (i) coordinating the α-phosphate and stabilizing the negative charge developed
on a phosphorane transition state (Hakansson et al., 1997; Nandakumar et al., 2006), and (ii)
coordinating the Lys-Nζ and favoring its deprotonation for nucleophilic attack on the α-
phosphorus.
The GTP triphosphate moiety in the vaccinia GTase is coordinated by basic residues in
motifs V (390DFKIKKENTID400) and VI (493RIDK496). Motif V comprises strands β18 and
β19 and their connecting loop, which joins the NTase module to the OB module. Motif V
Lys392, which is essential for RNA capping activity (Cong and Shuman, 1995), makes a
bifurcated contact via Nζ with the α-β bridging O3A and the β-phosphate O2B. Lys394
points towards the β-phosphate, but is not within hydrogen bonding distance. We suspect
that the vaccinia motif V lysine contacts with the phosphates may be reorganized in the
context of a Michaelis complex with Mg2+.
Motif VI (RxDK) in the OB module is essential for the activity of cellular GTases (Sawaya
and Shuman, 2003; Wang et al., 1997). Motif VI of Chlorella virus GTase is located in a
loop (295RSDKNQAN302) connecting a β strand and an α helix of the OB domain and is
similarly situated in the S. cerevisiae, C. albicans, and human GTases. In the catalytically
poised closed conformation of Chlorella virus GTase, Arg295 coordinates the GTP β
phosphate while Lys298 and Asn302 engage the γ phosphate, thereby orienting the PPi
leaving group apical to the lysine nucleophile. However, in the vaccinia GTase, motif VI
resides entirely within helix αI (493RIDKTMKYN502). Despite the distinctive secondary
structure of motif VI in the poxvirus enzyme, the Arg493 and Lys496 side chains engage the
GTP γ-phosphate oxygens, signifying a functional correspondence to motif VI of the
cellular and Chlorella virus GTases. Lys496 also makes a salt bridge to the putative metal-
binding Asp400 carboxylate. Vaccinia residue Asn502 occupies a position similar to that of
Asn302 in Chlorella virus GTase, but it is 5 Å away from the GTP γ-phosphate, again
suggestive that the Vaccinia active site configuration is non-active.
In sum, the structure of the GTase teaches us that the poxvirus capping enzyme shares
features of NTP recognition and catalysis with other viral and cellular capping enzymes, and
with polynucleotide ligases, while highlighting multiple distinctive components of the
poxvirus active site.
Kyrieleis et al. Page 8
Structure. Author manuscript; available in PMC 2015 March 04.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
The interface between TPase and GTase
The TPase (Cet1) and GTase (Ceg1) components of the S. cerevisiae capping apparatus are
encoded as separate polypeptides that associate in vivo and in vitro to form a stable
Cet1•Ceg1 complex. The Cet1•Ceg1 crystal structure revealed a hetero-tetramer composed
of one Cet1 homodimer and two molecules of Ceg1 (Gu et al., 2010). The main Cet1•Ceg1
interaction surface (1900 Å2) is between the OB domain of Ceg1 and the extremity of the N-
terminal extension of the distal Cet1, after the latter has crossed over the proximal subunit of
the Cet1 homodimer. There is minimal interaction of the NTase module of Ceg1 with Cet1,
thereby allowing flexibility between the OB and NT domains.
The vaccinia TPase-GTase interface differs significantly from that of Cet1 and Ceg1,
although both bury comparable surface accessible areas (2155 Å2 in the vaccinia interface
versus 2400 Å2 for the Cet1-Ceg1 interface). The main difference is that the vaccinia TPase
makes substantial interactions with the NTase (807 Å2) and OB (1348 Å2) modules of the
GTase, holding them in a closed conformation (Figure 4A). In comparison, Ceg1 GTase is
in a wide open conformation (Gu et al., 2010). The vaccinia TPase contacts the GTase
mainly via the helices packed against the TPase β-barrel and the loops connecting these
helices to the tunnel. This results in a more rigid connection between the two enzymes, in
contrast to the flexible connection between Cet1 and Ceg1. Finally, the relative orientation
of the TPase tunnel to the GTase differs markedly. In the vaccinia enzyme the tunnel
entrance points directly towards the GTase active site (Figure 6), whereas in the Cet1-Ceg1
structure the tunnel is rotated almost 45° around the axis perpendicular to the longitudinal
tunnel with the entrance pointing towards the OB-fold domain of Ceg1.
The interface of the vaccinia TPase and GTase comprises three separate sub-interfaces
between: (a) the TPase N-terminal peptide and residues of the GTase β-strand β11 of the
central β-sheet and the long N-terminal loop located on top of the central β-sheet; (b) the
TPase helix αB and GTase residues in helix αI and β24 of the OB domain and (c) the TPase
residues in αD and the loop connecting αD with β8 and GTase OB residues from β21, β24,
β25, their connecting loops and helix αI. These interfaces are illustrated in Figure 4 and
described in more detail in the supplementary information.
Mutational analysis of the TPase-GTase interface
To address the importance of the inter-domain contacts for capping enzyme function, we
introduced interfacial mutations T10A, L47A-L50A-T51A, N181A, and R186A in the
TPase domain and K478A in the GTase domain of D1-(1-545) and assayed the affinity-
purified wild-type and mutant recombinant proteins (Figure S3A) for TPase and GTase
activities. We purified and tested in parallel a TPase-defective mutant E192A that eliminates
one of the metal-binding side chains in the TPase active site tunnel. Velocity sedimentation
analysis of the wild-type D1-(1-545) protein verified that it sedimented as a discrete
monomeric component and that the GTase and TPase activity profiles coincided with that of
the D1-(1-545) polypeptide (Figure S3B,C). The relative activities of the D1-(1-545)-Ala
mutants vis à vis the wild-type enzyme are shown in Figure 4D. As noted above, our
criterion for deeming an amino acid important for capping enzyme function is that its
replacement by alanine elicits at least a four-fold decrement in activity. There was a clear
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hierarchy of mutational effects, the most instructive of which were the lesions that resulted
in a complete separation of function. For example, the E192A enzyme with a TPase active
site mutation was fully active as a guanylyltransferase, but was crippled as a triphosphatase
(4% of wild-type activity) (Figure 4D). Two of the interfacial mutations, L47A-L50A-T51A
in the TPase domain and K478A in the GTase domain, reduced GTase activity to <1% of the
wild-type level while sparing the TPase (42-43% of wild-type activity). Lys478 is at the
center of a rich network of cross-domain contacts between the δD helix and flanking loop of
the TPase domain and the OB domain of the GTase, especially the αI helix that includes
motif VI side chains needed for GTase activity (Fig. 4C). We surmise that the K478A
mutation destabilizes the active conformation of the GTase. Note that other mutations in this
portion of the interface (N181A and R186A) did not exert a significant or selective impact
on GTase versus TPase activity (Figure 4D).
The L47A-L50A-T51A triple-mutation, which eliminates all of the atomic contacts between
the TPase αB helix and the OB domain of the GTase (including the direct contacts of Leu47
to the αI helix), also abolished GTase activity while preserving substantial TPase function
(Figure 4D). These results highlight the key role of the TPase interface with the OB domain
as a determinant of guanylyltransferase activity. TPase interactions with the NTase domain
are also relevant, insofar as the TPase T10A mutation, which severs the contacts to
the 224PEVV227 peptide at the proximal margin of the NTase domain, results in a 5-fold
decrement in GTase activity with no effect on the TPase (Figure 4D).
These findings explain the long-standing conundrum in analysis of the domain organization
of vaccinia capping enzyme, whereby it has not been possible to define by N-terminal
deletion an autonomous GTase domain.
The interface between the GTase and MTase domains
A comparison with the previously described MTase•D12 structure (De la Pena et al., 2007)
reveals no significant structural differences of the sub-complex in the full length capping
enzyme. The vaccinia MTase is connected to the GTase via a flexible linker (residues
529-543) that is disordered in all crystal structures. This is followed by a region containing
several residues required for the coordination of the methyl-donor AdoMet and for catalysis
(De la Pena et al., 2007; Zheng and Shuman, 2008a). In the full length capping enzyme this
peptide is well defined in the P21 crystal form 1 but residues 553-561 are disordered in the
P1 crystal form.
The crystal structure of full length D1•D12 provides the first visualization of an interface
between an RNA (guanine-N7)-methyltransferase and an RNA guanylyltransferase. This
interface buries a surface area of around 917 Å2 (432 Å2 with NT and 485 Å2 with OB),
which is significantly less than the TPase–GTase interface. The secondary structure
elements of the MTase contributing to the interface include the N-terminal peptide, helix
αO, the β-strands β33, β34, β35 (inserted between β31 and αQ) and their connecting loops.
Their GTase components at the interface are β9, αF, β17 and β18 from the NTase module
and β20, β21 and αJ from the OB module. This interface is illustrated in Figure 5A and
described in more detail in the supplementary information.
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The interface between the MTase catalytic domain and D12
We previously described the interface between the vaccinia MTase with the stimulatory D12
subunit and proposed a mechanism for the allosteric effect of D12 on the MTase activity,
whereby the D12 helix αB’ packs against the C-terminal part of the MTase helix αK mainly
via hydrophobic interactions. This interaction stabilizes this helix, which contains Asn570
and Lys573, two conserved residues coordinating the methyl acceptor GTP and the methyl
donor AdoMet, respectively (De la Pena et al., 2007). To further investigate this interface
we introduced alanine mutations for MTase residues Tyr571, Leu575, Leu576, Met579,
Phe585, Leu586, Asp587, Asp784, Asn785, Arg794, Phe798, Met805 and Glu806 at the
interface with the D12 subunit. The His-tagged wild-type and mutant MTase catalytic
domains D1-(540-844) were co-expressed in E. coli with untagged D12. SDS-PAGE
analysis of the affinity-purified proteins revealed that D12 co-purified with D1-(540-844) in
every case (Figure S4A), signifying that none of the interfacial mutations affected the
heterodimerization of the MTase catalytic domain with D12 during protein production in
vivo in bacteria. The recombinant proteins were assayed for methyltransferase activity by
label transfer from [3H-CH3]AdoMet to GpppA cap dinucleotide. None of the alanine
changes elicited a significant decrement in MTase activity (Figure S4B). In addition we
tested the effects of the alanine mutations on cap methylation activity in vivo in yeast, taking
advantage of the fact that co-expression of vaccinia D1 MTase catalytic domain and the D12
stimulatory subunit in S. cerevisiae complements the lethality of a yeast abd1Δ mutant that
lacks the endogenous yeast cap guanine-N7 methyltransferase enzyme Abd1 (Saha et al.,
2003). Co-expression of both vaccinia subunits is required for abd1Δ complementation and
the genetic readout is sensitive to D1 mutations that affect methyltransferase catalytic
activity (Saha et al., 2003; Zheng and Shuman, 2008a, b) and to certain D12 mutations (Saha
et al., 2003; Schwer and Shuman, 2006). Here we found that all of the interfacial alanine
mutants in the D1 MTase were active in abd1Δ complementation (Figure S4B). We
conclude that none of the residues probed by alanine scanning at the MTase-•D12 interface
is critical per se for biochemical or biological activity.
Discussion
The vaccinia virus mRNA capping enzyme combines all three enzymatic activities for cap 0
synthesis within one polypeptide chain. Our current and previous (De la Pena et al., 2007)
structural studies reveal that the folds of the single components are similar to capping
enzyme components already structurally characterized: the TPase belongs to the
triphosphate tunnel metalloenzyme (TTM) family that includes yeast and mimivirus RNA
triphosphatases, the GTase is a member of the covalent nucleotidyltransferase superfamily
that comprises capping enzymes and polynucleotide ligases, and the MTase belongs to the
class I family of AdoMet-dependent MTases.
The unification of the vaccinia RNA triphosphatase with the TTM family resolves a
longstanding conundrum about the structure and origins of this enzyme. Early studies of the
vaccinia TPase revealed what would emerge as the signature biochemical feature of the
TTM-type RNA triphosphatases: the ability to hydrolyze NTP to NDP and Pi in the presence
of Mn2+ or Co2+ (Shuman et al., 1980). The yeast Cet1 structure unveiled a then novel
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tunnel tertiary structure (Lima et al., 1999) that has since been recognized as the founder of
a TTM superfamily that extends well beyond capping enzyme TPases (Gong et al., 2006;
Jain and Shuman, 2008). Amino acid sequence comparisons and mutational analyses of
metal-dependent RNA triphosphatases of fungi, microsporidia, protozoa and Chlorella virus
highlighted conservation of the β strands and essential amino acids that compose the active
site tunnel of yeast Cet1, implying a common structure and evolutionary origin for these
enzymes (Shuman, 2002), a view later fortified by the structure of mimivirus TPase
(Benarroch et al., 2008). However the vaccinia TPase had no recognizable primary structure
similarity to the fungal, protozoan, Chlorella virus or mimivirus TPases, except for the
metal-binding motifs A and C. Whereas mutational studies had identified constituents of the
vaccinia TPase active site, and it was predicted that some of these would reside in β strands
(e.g., 74VKIRTKI80 and 158IDFKLKY164), it was inferred that the poxvirus TPases lack a
topologically closed tunnel architecture (Gong and Shuman, 2003). The present structure
vitiates that notion, while at the same time showing that several of the active site
constituents of vaccinia TPase are indeed deployed in a distinctive manner (i.e. in different β
strands of the tunnel) vis à vis other TTM RNA triphosphatases.
The structure of the full-length D1 protein adds new information on the disposition of the
catalytic domains and their interfaces. The N-terminal decapeptide and tunnel-surrounding
helices of the TPase domain interact, respectively, with the NTase and OB modules of the
GTase domain. In this way, the vaccinia TPase clamps the GTase in a conformation similar
to the closed conformation of Chlorella virus capping enzyme, but unlike the Cet1-Ceg1
complex or the isolated C. albicans and human GTases, in which the relative orientation of
the NTase and OB modules is flexible. It is therefore unlikely that the vaccinia GTase
undergoes the same degree of inter-NTase–OB domain movement as observed in Chlorella
virus and cellular GTases and ATP-dependent DNA ligases. Consistent with this idea is our
observation that residues in the vaccinia TPase/GTase interface have profound effects on
GTase activity. In particular, the mutations L47A-L50A-T51A, K478A and T10A resulted
in separations of function, whereby the mutant enzymes were inactive or partially defective
in TPase activity, but spared with respect to GTase function.
The salient characteristic of the open conformations of GTases and DNA ligases is that
motif VI is remote from the NTP β and γ phosphates. In the vaccinia GTase, motif VI
engages the GTP phosphates, but the geometry of the triphosphate moiety observed in our
structure is inimical to catalysis. We presume that the triphosphate conformation and certain
atomic contacts of the active site functional groups will be remodeled in the Michaelis
complex of the GTase reaction, especially when the catalytic Mg2+ engages the GTP α-
phosphate and the non-catalytic Mg2+ bridges the β- and γ-phosphates.
The orientation of the TPase tunnel relative to the GTase active site in the vaccinia capping
enzyme is well suited for sequential action. Although bound nucleoside triphosphate
substrate has not been observed in any available RNA triphosphatase structure, it is
hypothesized from positions of a bound divalent cation and a sulphate (mimicking the γ-
phosphate) in the yeast Cet1 TPase structure that the 5′ pppRNA end substrate enters the
tunnel from the direction depicted in Figure 6. In the vaccinia system, the TPase tunnel is
positioned so that its entrance points directly towards the GTase active site. Based on the
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vaccinia enzyme structure, we can imagine that the mRNA 5′ triphosphate end enters the
deep groove formed by the TPase, OB-fold and MTase, giving it access to the TPase and
then, after conversion to a 5′ diphosphate RNA, to the GTase active site (Figure 6 left). By
contrast, the transition from the GTase to the MTase active site is less clear, insofar as the
MTase site is on the opposite side of the D1•D12 heterodimer (Figure 6 right). It is possible
that the GpppRNA continues to track around the protein surface in the same direction in the
groove between the NTase, MTase and D12 subunits (path A), taking advantage of the U-
shaped form of the complex, but this is a long way round. Alternatively the GpppRNA could
dissociate from the GTase and rebind to the MTase active site (path B). In any case, it
should be borne in mind that the capping enzyme is directly associated with the vaccinia
RNA polymerase (Hagler and Shuman, 1992) so that the 5′ end of the nascent mRNA will
stay in proximity to the capping enzyme even if dissociated from a particular capping
enzyme active site. Furthermore, mRNA elongation by the polymerase could be a driving
force to move the 5′ end from one active site to the next. Although our structures provide
new insights to the architecture of the complete vaccinia capping enzyme, we must await a
next generation of structures of the enzymes in complexes with pppRNA, ppRNA and
GpppRNA ligands to illuminate how the mRNA 5′ end proceeds from one site to the next
and whether significant conformational changes, not so far observed in any crystal form,
play a role in these transitions.
The D1•D12 structure, the first of a complete trifunctional DNA virus capping enzyme,
raises interesting questions about the evolution of the mRNA capping apparatus. The
poxvirus D1 subunit comprises TPase, GTase and MTase catalytic domains, arrayed in the
same linear order in the D1 polypeptide as the sequential capping reactions they perform.
The structural similarities of the poxvirus TPase, GTase and MTase modules to the
separately encoded TPase, GTase, and MTase enzymes of fungi and microsporidia (Fabrega
et al., 2004; Fabrega et al., 2003; Lima et al., 1999) argues that the poxvirus capping enzyme
evolved by gene fusion events. The fact that other large eukaryal DNA viruses, such as
African swine fever virus and mimivirus, also encode D1-like TPase-GTase-MTase
polypeptides (Benarroch et al., 2008; Pena et al., 1993), as do virus-like cytoplasmic
plasmids of fungi (Tiggemann et al., 2001), suggests a common ancestry for the DNA virus
and virus-like trifunctional capping enzymes (Shuman, 2002).
New clues to this ancestry can be found in the growing collection of giant DNA viruses that
have been isolated from marine protozoa and eukaryal phytoplankton in the wake of the
discovery of mimivirus. The giant DNA viruses that encode poxvirus/mimivirus-like TPase-
GTae-MTase polypeptides are as follows (with viral genome size and capping enzyme
polypeptide accession number and size indicated in parentheses): Megavirus chiliensis (1.26
Mb; YP_004894563: 1164 aa); Acanthamoeba polyphaga moumouvirus (1.02 Mb;
YP_007354410: 1162 aa); Cafeteria roenbergensis virus (0.73 Mb; YP_003969844: 1015
aa); Phaeocystis globosa virus (0.46 Mb; YP_008052553: 1191 aa); Marseillevirus (0.37
Mb; YP_003407048: 819 aa); and Organic Lake phycodnavirus 2 (~0.3 Mb; ADX06468:
942 aa). By contrast, the largest known eukaryal DNA virus, Pandoravirus salinus (2.5 Mb
genome) encodes three separate capping enzymes: a TTM-type TPase (YP_008436986: 333
aa), a GTase (YP_008437195: 482 aa), and a MTase (YP_008436891: 452 aa).
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The D12 subunit is a distinctive feature of the poxvirus capping enzyme. As noted
previously, the D12 structure resembles a degenerate cap 2′-O-MTase domain, insofar as it
is structurally similar to the cap 2′-O-MTases of reovirus λ and flavivirus RNA polymerase,
whilst lacking the AdoMet binding site (De la Pena et al., 2007). We surmise that poxvirus
D1•D12 descended from a multi-functional viral enzyme that was capable of synthesizing a
cap 1 structure, m7GpppNm. Erosion of the erstwhile MTase function of vaccinia D12 was
presumably compensated by the acquisition of a separately encoded cap 2′-O-MTase
enzyme, VP39 (Schnierle et al., 1992). There is apparent selective pressure to maintain D12
as a subunit of the vaccinia capping enzyme, by virtue of: (i) its necessity for optimal MTase
activity of the D1 subunit; and (ii) its requirement for the transcription termination factor
activity of vaccinia capping enzyme during synthesis of poxvirus early mRNAs by the viral
RNA polymerase (Luo et al., 1995).
PDB deposition
Co-ordinates and structure factors have been deposited in the wwPDB for the P21 (code
4CKC) and P1 (code 4CKE) forms of the SAH bound trifunctional enzyme and the SAH
and GTP bound P1 form (code 4CKB).
Material and Methods
Full methods are given in the supplementary information.
Expression and crystallisation of vaccinia capping enzyme
D1, with an N-terminal tobacco etch virus (TEV) protease cleavable His10-tag, was co-
expressed with D12 in E. coli strain BL21Star(DE3)pLysS and the complex purified by two
steps of Ni-NTA affinity chromatography (before and after His-tag cleavage by His-tagged
TEV), followed by heparin and then Superdex 200 columns (Pharmacia). Purified complex
at 4 mg/ml was used with 5 mM AdoMet, 1 mM magnesium chloride, and 2 mM m7GpppG
for crystal screening. After optimization, plate-like crystals, often in stacks, were grown
from 0.1 M MES, pH 6.0, 1 M LiCl, 10% PEG-6000 at 20°C using the sitting drop vapor-
diffusion technique. These crystals belong to space group P1 with two molecules per
asymmetric unit (form 2). Crystals with similar morphology were grown from 0.1 M Tris-
HCl, pH 7.5, 0.2 M LiCl, 0.2M (NH4)2SO4, 15% PEG-4000. These crystals belong to the
space group P21 with two molecules per asymmetric unit (form 1). Form 1 crystals
containing GTP were grown in the presence of 100 mM GTP, 5 mM manganese chloride,
and 5 mM AdoMet from 0.1 M citric acid, pH 6.5, 1.2 M LiCl, 6% PEG-6000.
Data collection, phase determination and structure refinement
Diffraction data from cryo-protected crystals were collected at the European Synchrotron
Radiation Facility (ESRF) beamlines and processed with XDS (Kabsch, 1993). The D1•D12
structure was solved by molecular replacement, using the MTase•D12 subcomplex (pdb
2VDW, 51% of the total), in combination with cross-crystal averaging over four data sets
and the two D1•D12 complexes in each asymmetric unit: native datasets in P21 and P1, a
selenomethionine labelled derivative and a non-isomorphous platinum derivative, with
resolutions of 2.9 Å, 2.9 Å 3.5 Å and 3.2 Å, respectively. The RESOLVE-build script,
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which performs automatic, iterative, density modification, NCS averaging and model
building, was very useful model construction (Terwilliger, 2003). Structures were refined
with standard procedures using NCS restraints and TLS parameters.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• 2.8 Å resolution crystal structure of the complete vaccinia capping enzyme
• The TPase has a triphosphate tunnel metalloenzyme fold
• The extensive TPase-GTase interface clamps the GTase in a closed
conformation.
• TPase-GTase interfacial mutations selectively cripple the GTase activity.
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Figure 1. Overall structure and topology
(A) The three reactions catalyzed by respectively the TPase, GTase and MTase to generate the cap 0 structure.
(B) Schematic diagram showing varying architecture of viral capping enzymes.
(C) Overall ribbon representation of the full-length capping enzyme showing separate domains. The TPase is colored in purple,
the NTase in green, the OB-fold in grey, the MTase in red and the D12 subunit in yellow, as in (B). The bound SAH and GTP
molecules are shown as sticks.
(D) Schematic topology diagram of the full-length capping enzyme with secondary structure elements labeled. The domains are
colored as in (C).
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Figure 2. The triphosphatase domain. See also Figure S1
(A) Two orthogonal views of the vaccinia TPase in ribbon representation with secondary structure elements labeled as in Figure
1D and the structure based alignment of Figure S1D. (B-D) Comparison of TPase tunnel interiors of the vaccinia (B), Mimivirus
(C) (PDB entry 2QZE) and yeast Cet1 (D) (PDB entry 1D8I) enzymes. The structural similarity of vaccinia TPase as given by
DALI to that of Mimivirus is RMSD of 3.8 Å over 183 aligned Cα positions, 12% sequence identity, Z-score 12.8 and to Cet1 is
RMSD of 3.5 Å for 163 aligned Cα positions, 15% sequence identity, Z-score 9.8. Waters are depicted as red spheres. The
manganese ion in the active site of Cet1 is shown as a purple sphere. The bound acetate (Mimivirus) and sulphate (Cet1) ions
are shown as sticks. Selected amino acid side chains in the vaccinia, mimivirus and Cet1 tunnels are depicted as stick models
with blue, gray and red carbons, respectively. Residues of TPase motifs A, B and C are colored in black, green and brown,
respectively, in B, C and D (See also Figure S2).
Kyrieleis et al. Page 21
Structure. Author manuscript; available in PMC 2015 March 04.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 3. The guanylyltransferase domain. See also Figure S2
(A) Ribbon representation of the vaccinia virus GTase in green with bound GTP and secondary structure elements labelled.
Residues of the defining structural motifs I, III, IIIa, IV and V of the covalent nucleotidyl-transferase family are highlighted and
labelled in red, purple, blue, black and brown, respectively. The same color coding and labelling is used in 3B, 3C and 3D.
(B) Stereo view of the active site of the vaccinia GTase showing bound GTP and key interacting residues with hydrogen bonds
indicated by dotted black lines.
(C) Ribbon representation of the Chlorella virus GTase with bound GTP in the closed conformation (PDB entry 1CKN chain B,
light grey). The structural similarity of vaccinia GTase as given by DALI to that of Chlorella virus is an RMSD of 3.2 Å over
216 aligned Cα positions, 17% sequence identity, Z-score 14.7.
(D) Active site of the Chlorella virus GTase in the closed conformation with bound GTP.
(E) Superposition of vaccinia (green) and the closed form of Chlorella virus (grey) GTases (grey), both with bound GTP. The
angles between the NTase and OB-fold domains are indicated.
(F) Superposition of vaccinia GTase with bound GTP (green) and the open form of the Chlorella virus GTase with bound
GpppG (grey). The angles between the NTase and OB-fold domains are indicated. The angle between the vaccinia domains does
not change, whereas that of Chlorella virus opens with GpppG present.
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Figure 4. The TPase/GTase interface. See also Figure S3
(A) Overall ribbon representation of the vaccinia TPase /GTase interface, with coloring as in Figure 1C and secondary structural
elements involved in the TPase/GTase interface labelled.
(B) and (C) Close-up stereo views of the corresponding areas marked in (A). For clarity the view in (B) is shown 180° rotated
around the Y-axis, allowing a view from the rear of the interface. Side chains involved in interface formation are shown as stick
models, hydrophobic interactions and hydrogen bonds are presented as dotted lines in magenta and black, respectively.
(D) Effects of alanine mutations at the TPase/GTase interface on TPase and GTase activity. Guanylyltransferase reaction
mixtures (20 μl) containing 50 mM Tris-HCl (pH 8.0), 5 mM DTT, 5 mM MgCl2, 5 μM [α32 P]GTP, and 200 ng wild-type or
mutant His10Smt3-D1-(1-545) were incubated for 5 min at 37°C. The reactions were quenched with SDS and the products were
analyzed by SDS-PAGE. The covalent enzyme-[32P]GMP complex was visualized by autoradiography of the dried gel and
quantified by scanning the gel with a phosphorimager. Triphosphatase reaction mixtures (10 μl) containing 50 mM Tris-HCl
(pH 8.0), 2 mM DTT, 10 mM MgCl2, 1 mM [α32P]ATP, and 150 ng wild-type or mutant His10Smt3-D1-(1-545) were incubated
for 30 min at 37°C. The reactions were quenched with 20 mM EDTA. An aliquot (6 μl) of the reaction mixture was spotted on a
polyethyleneimine-cellulose TLC plate, which was developed in 0.45 M (NH4)2SO4. The release of [α32P]ADP was quantified
by scanning the TLC plate with a phosphorimager. The GTase and TPase activities of the mutants were normalized to the wild-
type activity (defined as 100%).
Kyrieleis et al. Page 23
Structure. Author manuscript; available in PMC 2015 March 04.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 5. MTase interfaces with GTase and D12. See also Figure S4
(A) Left: Overall ribbon representation of the vaccinia GTase/MTase interface. The colour scheme is as in Figure 1C. Secondary
structure elements contributing to the interface are labeled. Right: Stereo view of the marked area in left hand diagram. Side
chains involved in the interface and SAH are shown as stick models, hydrophobic interactions and hydrogen bonds are presented
as dotted lines in magenta and black, respectively.
(B) Same as (A) but for the MTase/D12 interface.
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Figure 6. mRNA cap synthesis pathway between active sites
Two orthogonal views of the complete trifunctional enzyme, in ribbon and surface representation, showing the spatial
relationship between the three active sites. The colour scheme is as in Figure 1C and ligands GTP and SAH are shown as space-
filling models. Dotted black arrows and brackets indicate ligands that are obscured in a particular view. Possible paths of the
mRNA 5′ end to enter successively the TPAse, GTase and MTase are shown in red (see text).
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